Prazosin Alcohol Dependence IVR Study

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Alcoholism
Interventions
DRUG

prazosin

"Pharmacological treatment: In order to prevent the possible side effect of first-dose hypotension, all participants will receive only 1mg of study medication or placebo nightly for the first two days of study participation. Titration will proceed according to the following schedule:~Prazosin Dosing: 9 AM 3 PM 9 PM Days 1-2 1 mg (one capsule) Days 3-4 1 mg 1 mg 1 mg Days 5-7 2 mg 2 mg 2 mg Day 8-10 2 mg 2 mg 6 mg Day 11-14 4 mg 4 mg 6 mg Day 15-42 4 mg 4 mg 8 mg"

Trial Locations (1)

98108

VA Puget Sound Health Care System, Seattle

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

University of Washington

OTHER

NCT00167687 - Prazosin Alcohol Dependence IVR Study | Biotech Hunter | Biotech Hunter